State-by-state legalization of marijuana is opening eyes to the possible health benefits from parts of the cannabis plant, but the federal government remains an obstacle, as Martin A. Lee explained to Dennis J Bernstein.
Despite breakthroughs in understanding the curative possibilities of CBD — essentially the non-psychoactive part of the cannabis plant — the stigma of marijuana’s criminalization is delaying progress as is the refusal of the federal government to support state-by-state legalization.
I spoke with Martin A. Lee, the director of Project CBD and a leading expert on the breakthroughs and breakdowns when it comes to the use of CBD as a healing tool on April 20, 2017. Lee is also the author of Smoke Signals: A Social History of Marijuana – Medical, Recreational, and Scientific
Dennis Bernstein: Okay. Well, let’s just start with a sweeping overview. Trump is in. We’ve got an extremely right-wing attorney general. On the macro level do you anticipate… is there a sense that the landscape is changing?
Martin Lee: No one really knows what lays ahead. Obviously, the uncertainty coming from the federal government is problematic for the “cannabis industry” – we used to call it a community, now it’s an industry.
But there are also countervailing forces. You know, Trump’s folks have talked about coming down on the recreational market, as opposed to medical. They seem to be conceding medical. But there are countervailing forces particularly with respect to the CBD industry. CBD, cannabinoid, as you are mentioning, is basically a non-psychoactive component of the cannabis plant with a lot of therapeutic applications.